Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

The HSP90 chaperone machinery

(2017) Florian H. Schopf et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells

(2017) Y Nishida et al.   Blood Cancer Journal

Triple negative breast cancer: the kiss of death

(2017) Adriana-Andreea Jitariu et al.   Oncotarget

Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells

(2017) Shih-Ming Chen et al.   Oncotarget

Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation

(2017) Mathangi Srinivasan et al.   Oncotarget

Global Cancer Incidence and Mortality Rates and Trends--An Update

(2015) L. A. Torre et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

(2015) Che-Hsin Lee et al.   Oncotarget

Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog

(2014) Anurag N Paranjape et al.   BMC CANCER

Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1

(2014) Yu-Chao Chang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Polycomb group proteins and MYC: the cancer connection

(2013) Leonidas Benetatos et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Sp1 and c-Myc regulate transcription ofBMI1in nasopharyngeal carcinoma

(2013) Hong-Bo Wang et al.   FEBS Journal

Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells

(2012) Che-Hsin Lee et al.   BIOCHIMIE

Cancer stem cells niche: A target for novel cancer therapeutics

(2012) Shan-Yong Yi et al.   CANCER TREATMENT REVIEWS

A Positive Feedback Loop Regulates the Expression of Polycomb Group Protein BMI1 via WNT Signaling Pathway

(2012) Joon-Ho Cho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences

(2012) Hifzur Rahman Siddique et al.   STEM CELLS

BMI1 as a novel target for drug discovery in cancer

(2011) Liangxian Cao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells

(2011) F. Neri et al.   MOLECULAR AND CELLULAR BIOLOGY

The Mineralocorticoid Receptor Is a Constitutive Nuclear Factor in Cardiomyocytes due to Hyperactive Nuclear Localization Signals

(2010) Iván Hernández-Díaz et al.   ENDOCRINOLOGY

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors

(2010) Ramesh K. Ramanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

(2010) Anna Maria Calcagno et al.   JNCI-Journal of the National Cancer Institute

Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy

(2010) Stuart J Schnitt   MODERN PATHOLOGY

Cancer stem cells in solid tumors

(2010) Patrick C. Hermann et al.   SEMINARS IN CANCER BIOLOGY

EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance

(2009) M.-L. Suva et al.   CANCER RESEARCH

Breast cancer chemoresistance: Emerging importance of cancer stem cells

(2009) Suebwong Chuthapisith et al.   SURGICAL ONCOLOGY-OXFORD

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1

(2008) J B Arnes et al.   HISTOPATHOLOGY